Physician profile

David Barquin

Durham, NC

NPI 1811576473

$1,615.34

in general payments reported to CMS, 2019-2025

6 companies · $1,452 in 2025

The $1,452 reported for 2025 was more than what 91% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$841.12
Food and Beverage$774.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,133.35 2025 Accolade Sr
Coloplast Corp $178.55 2025
Photocure INC $120.78 2025 Cysview
Axonics, INC. $105.24 2024 Axonics
Olympus America INC. $58.46 2024 Soltive, Uretero-Reno Fiberscope
Medtronic, INC. $18.96 2025 Interstim

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Barquin

$1,615.34

in general payments reported 2019-2025

Years
2024-2025
Top company
Boston Scientific Corporation
Context
The $1,452 reported for 2025 was more than what 91% of providers received nationally.

https://glasscript.com/doctor/11692329/david-barquin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.